Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 28, 2017; 23(24): 4399-4406
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4399
Table 3 Univariate disease-free survival analysis of prognostic factors for patients with pancreatic cancer
Mean DFI time (mo) (95%CI)Median DFI time (mo) (95%CI)P value
Grading (G)
1-232.438 (24.808-40.068)13.000 (8.597-17.403)< 0.01
310.438 (8.011-12.865)8.000 (7.183-8.817)
Radicality
R029.886 (22.892-36.880)12.000 (9.280-14.720)0.001
R112.708 (6.744-18.671)8.000 (6.256-9.744)
Staging
I-II27.222 (20.732-33.711)12.000 (9.814-14.186)0.126
III-IV19.772 (9.939-29.604)8.000 (6.976-9.0224)
Lymph nodes status
Neg34.386 (20.868-47.904)13.000 (9.523-16.477)0.106
Pos21.468 (16.504-26.432)10.000 (7.686-12.314)
Number of positive lymph nodes
< 330.817 (21.628-40.006)10.000 (6.746-13.254)0.150
> 320.326 (14.615-26.036)11.000 (8.082-13.918)
lymph node ratio
≤ 0.1330.576 (22.593-38.560)12.000 (9.211-14.789)0.155
0.13-0.217.500 (5.595-29.405)8.000 (6.614-9.366)
> 0.217.397 (11.191-23.603)13.000 (8.840-17.160)
Para-aortic lymph nodes status
Neg28.206 (21.656-34.756)12.000 (9.808-14.192)0.005
Pos11.957 (6.132-17.781)8.000 (6.853-9.147)